EternaVita is our innovative development for healthy longevity
EternaVita is the result of a modern understanding of the nature of aging. Our goal is to offer a solution that acts directly on the causes, rather than on the symptoms of decline
MiraxBioPharma is proud to announce the market launch of a new dietary supplement. EternaVita is a multitarget geroprotector formula featuring a unique composition developed to holistically target the core mechanisms of aging and support the prevention of age-related diseases.
Development of the supplement began in 2018. Our team has gathered modern scientific data in the fields of molecular biology, gerontology, and evidence-based medicine.
"EternaVita is the result of a modern understanding of the nature of aging. Our goal is to offer a solution that acts directly on the causes, rather than on the symptoms of decline," - commented Vadim Drukh, MiraxBioPharma's CEO.
EternaVita is designed to provide direct protection against a wide range of age-associated diseases, including cardiovascular pathologies, neurodegenerative disorders (Alzheimer's and Parkinson's diseases), oncological diseases, and neurological impairments. In addition, cycloastragenol, a key component of EternaVita, restores protective DNA structures and protects chromosomes from wear and tear.
EternaVita will appeal to an adult audience that takes a conscious approach to health preservation and is interested in preventive methods of counteracting age-related changes.
Learn more about EternaVita at eternavita.ru eternavita.ru
